- Thursday, May 29
- 9:45 AM
- Hall 406 CX - Engage Theatre 1, Suntec Singapore Convention & Exhibition Centre
AI-Driven Precision Medicine: Transforming Liver Transplant Decision-Making and Patient Care
ILTS is delighted to welcome Dr. Dean Ho as our Special Distinguished Speaker for the State-of-the-Art Lecture I!
ILTS is delighted to welcome Dr. Dean Ho as our Special Distinguished Speaker for the State-of-the-Art Lecture 1, taking place on Thursday, May 29, at 9:45 AM in Hall 406 CX – Engage Theatre 1, Suntec Singapore Convention & Exhibition Centre.
Dr. Ho is the Provost’s Chair Professor and Head of the Department of Biomedical Engineering at the College of Design and Engineering, Director of The Institute for Digital Medicine (WisDM) at the Yong Loo Lin School of Medicine, and Director of The N.1 Institute for Health (N.1) at the National University of Singapore.
He and his collaborators have developed groundbreaking technologies, including CURATE.AI, an AI platform personalizing treatments across oncology, digital therapeutics, and infectious diseases, and IDentif.AI, which optimizes combination therapy design for addressing SARS-CoV-2 and antimicrobial resistance. Recently, his team introduced WisDM Green, a platform addressing food security by optimizing yield while preserving nutritional content sustainably.
Read more about Dr. Ho
Dr. Ho is a Fellow of the US National Academy of Inventors (NAI), the American Association for the Advancement of Science (AAAS), the American Institute for Medical and Biological Engineering (AIMBE), and the Royal Society of Chemistry. His internationally recognized leadership in digital health earned him a place in the HIMSS Future50 Class of 2021, and his groundbreaking work has been featured by CNN, The Economist, National Geographic, Forbes, Washington Post, NPR, and more. He is also a Subgroup Lead in the World Health Organization (WHO) Working Group for regulating AI in health.
Dr. Ho has received numerous accolades, including the Tech Heroes from Crisis Pathfinder Award from the Singapore Computer Society, the NSF CAREER Award, the Wallace H. Coulter Foundation Translational Research Award, and the V Foundation for Cancer Research Scholar Award. Additionally, he served as the President of the Board of Directors of the Society for Laboratory Automation and Screening (SLAS).
We invite all attendees to join this highly anticipated lecture to gain valuable insights into how AI-driven precision medicine is transforming liver transplant decision-making and enhancing patient care. Don’t miss this unique opportunity to hear from one of the world’s leading innovators in digital health and precision medicine!
- Thursday, May 29
- 9:45 AM
- Hall 406 CX - Engage Theatre 1 The Suntec Convention Centre.
- Friday, May 30
- 9:45 AM
- Hall 406 CX - Engage Theatre 1, Suntec Singapore Convention & Exhibition Centre
Novel Nanotechnology Approach to Overcome Limitations of Systemic IL-2 in Tolerance
ILTS is Honored to Welcome Dr. Jamil Azzi as Our Special Distinguished Speaker for the State-of-the-Art Lecture II!
We are delighted to announce that Dr. Jamil Azzi will be delivering the prestigious State-of-the-Art Lecture II on Friday, May 30, at 9:45 AM in Hall 406 CX – Engage Theatre 1 at Suntec Singapore Convention & Exhibition Centre. His lecture, titled “Novel Nanotechnology Approach to Overcome Limitations of Systemic IL-2 in Tolerance” will highlight groundbreaking advancements in transplant immunology and innovative strategies to enhance immune tolerance through nanotechnology.
Dr. Azzi is an Associate Professor of Medicine at Harvard Medical School and serves as the Director of Kidney and Pancreas Transplantation at Brigham and Women’s Hospital. A distinguished immunologist and NIH-funded principal investigator, he leads a pioneering research program focused on understanding the immune-regulatory mechanisms in transplantation and autoimmunity. His work is dedicated to developing more targeted and safer therapeutic strategies, leveraging cutting-edge technologies such as nanotechnology, cell therapy, and immunoengineering to transform the field of transplantation.
Read more about Dr. Azzi
Dr. Azzi’s laboratory has also spearheaded genomic and proteomic innovations, leading to the development of diagnostic, prognostic, and predictive biomarkers for transplant recipients and inflammatory diseases. His research has resulted in the ExoTRU test, a first-in-class non-invasive biomarker for kidney transplant rejection, now licensed to ThermoFisher, marking a significant advancement in post-transplant monitoring.
Recognized internationally for his transformative contributions to transplant immunology and precision medicine, Dr. Azzi has published extensively in leading scientific journals and received multiple prestigious awards for his work. His innovative approaches to immune regulation, precision immunotherapy, and biomarker discovery continue to shape the future of transplantation.
We invite all attendees to join this highly anticipated lecture and gain exclusive insights into how nanotechnology and precision immunotherapy are redefining transplant medicine. This is an exceptional opportunity to hear from one of the world’s leading experts in transplant immunology and nanomedicine.
- Friday, May 30
- 9:45 AM
- Hall 406 CX - Engage Theatre 1, The Suntec Convention Centre.
- Saturday, May 31
- 9:45 AM
- Hall 406 CX - Engage Theatre 1, Suntec Singapore Convention & Exhibition Centre
Pushing the Boundaries with Innovative Robotic Technologies in Liver Transplantation: A Focus on Pediatric Applications
ILTS is Honored to Welcome Dr. Mohamed Rela as Our Special Distinguished Speaker for the State-of-the-Art Lecture III!
We are delighted to announce that Dr. Mohamed Rela will be delivering the prestigious State-of-the-Art Lecture III on Saturday, May 31, at 9:30 AM in Hall 406 CX – Engage Theatre 1 at Suntec Singapore Convention & Exhibition Centre.
Dr. Mohamed Rela is a pioneering figure in liver transplantation with over three decades of experience. He is the Chairman and Managing Director of Dr. Rela Institute & Medical Centre and one of the world’s foremost liver transplant surgeons.
His career highlights include performing over 6,000 liver transplants, including a Guinness World Record for a successful transplant on a five-day-old infant. He is a leader in robotic liver surgery and complex hepatobiliary procedures, conducting over 200 robotic liver surgeries and 450 complex hepatobiliary surgeries annually. Additionally, he has made significant contributions to surgical innovations, particularly in pediatric liver transplantation, pioneering split liver transplantation and other advanced techniques to optimize donor organ usage.
Read more about Dr.Rela
We invite all attendees to join this highly anticipated lecture to gain valuable insights into how cutting-edge robotic technologies are revolutionizing liver transplantation, with a special focus on pediatric applications. Don’t miss this unique opportunity to hear from one of the world’s leading pioneers in liver transplant surgery and innovation!
- Saturday, May 31
- 9:30 AM
- Hall 406 CX - Engage Theatre 1, The Suntec Convention Centre.
